Jingwen(王靖雯) completed her Master’s degree in radiation oncology at Fudan University Shanghai Cancer Center. She joined the laboratory in 2020 and is currently undertaking a PhD study. She focuses on using multimodality approaches including genome-wide CRISPR/Cas9 screening, scRNA-Seq and epigenome analysis in patient-derived organoids and tumor samples to discover and understand the critical factors which determine the treatment response in colorectal cancer.